DE3789633D1 - HTLV-III(LAV)Decke-Peptide. - Google Patents

HTLV-III(LAV)Decke-Peptide.

Info

Publication number
DE3789633D1
DE3789633D1 DE3789633T DE3789633T DE3789633D1 DE 3789633 D1 DE3789633 D1 DE 3789633D1 DE 3789633 T DE3789633 T DE 3789633T DE 3789633 T DE3789633 T DE 3789633T DE 3789633 D1 DE3789633 D1 DE 3789633D1
Authority
DE
Germany
Prior art keywords
lav
htlv
blanket
peptides
iii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3789633T
Other languages
English (en)
Other versions
DE3789633T2 (de
Inventor
Edgar Philip Heimer
Premkumar Eragam Reddy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of DE3789633D1 publication Critical patent/DE3789633D1/de
Publication of DE3789633T2 publication Critical patent/DE3789633T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • AIDS & HIV (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE3789633T 1986-05-27 1987-05-25 HTLV-III(LAV)Decke-Peptide. Expired - Fee Related DE3789633T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86681786A 1986-05-27 1986-05-27

Publications (2)

Publication Number Publication Date
DE3789633D1 true DE3789633D1 (de) 1994-05-26
DE3789633T2 DE3789633T2 (de) 1994-08-04

Family

ID=25348484

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3789633T Expired - Fee Related DE3789633T2 (de) 1986-05-27 1987-05-25 HTLV-III(LAV)Decke-Peptide.

Country Status (3)

Country Link
EP (1) EP0247557B1 (de)
JP (1) JPS62294697A (de)
DE (1) DE3789633T2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879212A (en) * 1986-04-02 1989-11-07 United Biomedical Inc. Peptide composition and method for the detection of antibodies to HTLV-III
FI872409A0 (fi) * 1987-05-29 1987-05-29 Labsystems Oy Foerfarande foer detektering av hiv-1 motkroppar.
SE8704185L (sv) * 1987-10-28 1989-04-29 Ferring Ab Nya peptider, artificiella antigener och immunoanalystestsatser
SE8705197D0 (sv) * 1987-12-30 1987-12-30 Jonas Blomberg New peptides, two diagnostic methods using the peptides and a medicament based on the peptides
IL88963A (en) * 1988-01-27 1996-05-14 Iaf Biochem Int Circular synthetic peptides and their mixtures for the detection of VIH antibodies and for the formation of vaccines
US6218102B1 (en) 1988-01-27 2001-04-17 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
US6210874B1 (en) 1988-01-27 2001-04-03 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
US6214537B1 (en) 1988-01-27 2001-04-10 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
US5241047A (en) * 1988-12-08 1993-08-31 Biochem Pharma Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
JPH01301699A (ja) * 1988-02-10 1989-12-05 Immulogic Pharmaceut Corp 難治性の感染症の治療用ペプチド
US5439792A (en) * 1989-06-02 1995-08-08 Genetic Systems Corporation Cysteine thiol-protected peptides for use in immunoassays
ATE162799T1 (de) * 1989-06-02 1998-02-15 Genetic Systems Corp Peptide mit thiolgeschütztem cystein zur verwendung in immuntests
DE69129207T2 (de) * 1990-01-16 1998-10-08 Orgenics Ltd Peptide, von Virus-HIV-Hüllen-Glycoproteinen abstammend, deren Verwendung zum Nachweis einer Infektion dieser Viren und für die Impfung gegen AIDS
FR2657017B1 (fr) * 1990-01-16 1995-08-18 Clonatec Sa Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-1, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida.
DE4102042A1 (de) * 1991-01-24 1992-07-30 Bayer Ag Substituierte aminosaeureamid-derivate deren herstellung und verwendung als fungizide
WO2005115992A1 (en) 2004-05-23 2005-12-08 Housey Pharmaceuticals, Inc. Theramutein modulators
US8431110B2 (en) 2005-05-23 2013-04-30 Hmi Medical Innovations, Llc. Compounds and method of identifying, synthesizing, optimizing and profiling protein modulators

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0020171A1 (de) * 1979-05-31 1980-12-10 John Martin Johnson Wiederverwendbare Behälter
US4774175A (en) * 1985-03-01 1988-09-27 Centocor, Inc. Immunochemical methods for the detection of antibody against HTLV-III
IE64785B1 (en) * 1985-04-08 1995-09-06 Genetic Systems Corp Expression of immunologically reactive viral proteins
US4629783A (en) * 1985-04-29 1986-12-16 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
JP2702911B2 (ja) * 1985-09-11 1998-01-26 ユナイテツド・バイオメデイカル・インコ−ポレ−テツド 合成ペプチド、並びにそれを用いたエイズおよびプリ・エイズの検出方法
GB8525615D0 (en) * 1985-10-17 1985-11-20 Hoffmann La Roche Polypeptides

Also Published As

Publication number Publication date
EP0247557A2 (de) 1987-12-02
EP0247557A3 (en) 1989-08-23
JPS62294697A (ja) 1987-12-22
EP0247557B1 (de) 1994-04-20
DE3789633T2 (de) 1994-08-04

Similar Documents

Publication Publication Date Title
DE3784370T2 (de) Stulpe.
DE3751210D1 (de) Schalteranordnung.
DE3788416T2 (de) Modulbauförmige antennengruppe.
DE3789633D1 (de) HTLV-III(LAV)Decke-Peptide.
DE3751598T2 (de) Bilderzeugungsverfahren.
DE3787548D1 (de) Makrolid-verbindungen.
NO871817D0 (no) Fremgangsmaate for xerotrykking.
DE3780503T2 (de) Abbildungsverfahren.
DE3765851D1 (de) Maskenanordnung.
DE3750215T2 (de) Schalter.
DE3787051D1 (de) Immunotestverfahren.
DE3786025D1 (de) Makrolid-verbindungen.
DE3766420D1 (de) Bestimmte 3-benzoyl-3-oxolactame.
DE3789738T2 (de) Ausschalter.
NO871953D0 (no) Forbedringer vedr. roekeartikler.
NO872506L (no) Elastomer-polyolefin-blandinger.
DE3761627D1 (de) Verbundachsaggregat.
FI863526A (fi) Saett att foerhindra uppkomsten av statisk elektricitet hos laminerade golvkorkplattor jaemte plattor haertill.
DE3771817D1 (de) Loesungsmittelbestaendige polyaetheramidimide.
ES2014461B3 (es) Muñeca.
DE3787037T2 (de) Halteschaltung.
NL184772B (nl) Rakelinrichting.
NO872386D0 (no) Peptider.
FI870058A0 (fi) Foerfarande foer framstaellning av baernstenssyramon/(2-dimetylamino)etylester/succinat.
DE3774988D1 (de) Peptidderivate.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee